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ATP13A2 (OMIM 610513) is a lysosomal P-type ATPase implicated in neurological disorders including 
Kufor-Rakeb Syndrome and Parkinson’s disease, providing protection against stressors such as α-
synuclein and heavy metal toxicity incited by Mn2+ and Zn2+. To date, the molecular function 
underlying ATP13A2’s protection remains uncertain, despite significant advances in its cellular 
contributions, with notable roles of ATP13A2 in lysosomal function, autophagy, mitochondrial 
maintenance and exosome release (reviewed in 1).  
Our recent work 2 uncovered a remarkable role of the N-terminus of ATP13A2, which compared to 
other P-type ATPases, contains an unusual hydrophobic stretch that first was predicted as an 
additional N-terminal transmembrane segment. However, we demonstrated that the N-terminus 
does not traverse the membrane, but rests on the cytosolic membrane surface of late endo-
/lysosomes where it may serve as a docking platform for lipids and proteins (Fig. 1) 2. In fact, we 
show that the signaling lipids phosphatidic acid (PA) and phosphatidylinositol(3,5)bisphosphate 
(PI(3,5)P2) interact with the N-terminal region. Biochemical evidence further indicated that ATP13A2 
may reside in an inactive autophosphorylated state and that both lipids stimulate catalytic 
autophosphorylation, suggesting that the lipids unlock ATP13A2 activity. This mechanism becomes 
relevant in a cellular model of PD, where we demonstrated that ATP13A2 activity provides protection 
to rotenone-induced mitochondrial stress, which depends on the availability of PA and PI(3,5)P2 2 
(Fig. 1).  
Lyso-PA, bis(monoacylglycero)phosphate and lyso-phosphatidylcholine do not interact with the N-
terminus of ATP13A2, indicating a high specificity towards PA and PI(3,5)P2, notably two lipids 
involved in endo-/lysosomal pathways that are implicated in neurodegeneration 2. PA is a conical 
phospholipid with a small anionic head group inducing a negative membrane curvature and 
promoting membrane fission and fusion. PA is also a local signaling lipid e.g. produced via the 
hydrolysis of phosphatidylcholine by phospholipase D (PLD). Of interest, PLD1 regulates α-synuclein 
clearance via autophagy pathways, which might depend on PA-mediated ATP13A2 activation 2.  
The low-abundance phosphoinositide PI(3,5)P2 predominantly exists in endo-/lysosomal 
compartments, functioning as an organelle tag. Mutations in the PI(3,5)P2 5-phosphatase FIG4 
trigger Charcot-Marie-Tooth Type 4J disease and Yunis-Varon syndrome, which are marked by 
neurodegeneration. PI(3,5)P2-deficiency in mice carrying mutations in Vac14, an activator of 
PIKFYVE, a lipid kinase which generates PI(3,5)P2 from PI(3)P, also results in neurodegeneration. 
PI(3,5)P2 regulates endo-/lysosome morphology, acidification, trafficking, membrane fusion/fission 
events and is implicated in autophagy. The cellular functions of PI(3,5)P2 might partially relate to 
ATP13A2, since loss of ATP13A2 results in neurodegeneration, an increased lysosomal pH and 
impaired autophagy 2.  
We further show that ATP13A2 mediates protection against rotenone-induced mitochondrial stress 
requiring both catalytic activity of ATP13A2 and the lipids PA and PI(3,5)P2. This hints to a lipid-
dependent activation of ATP13A2 that is important for mitochondrial homeostasis and/or clearance 2 
(Fig. 1). In fact, PA and PI(3,5)P2 may be markers of stress regulating mitochondrial fragmentation 
and clearance. The levels of PA control mitochondrial fragmentation and elongation 3, and 
suppressed by the phosphatase Ptpmt1 under basal conditions, PI(3,5)P2 increases under 
mitochondrial dysfunction, which induces mitochondrial fragmentation 4.  
Together, PA and PI(3,5)P2 are important for endo-/lysosomal membrane dynamics and 
mitochondrial homeostasis, suggesting that ATP13A2 might be implicated in vesicular transport, 
fusion or fission events that are coupled to mitochondrial homeostasis. Moreover, many of the 
interacting genes of YPK9, the ATP13A2 ortholog in yeast 1, and many of the established interacting 
proteins of the human ATP13A2 5 play a role in vesicular transport or mitochondrial function. So, how 
does ATP13A2 confer protection against mitochondrial stress and what would be the transport 
function of ATP13A2? The presented biochemical evidence of the catalytic autophosphorylation 
reaction refutes any direct stimulation of activity by Zn2+ or Mn2+, suggesting that ATP13A2 may not 
directly transport heavy metals 2. Instead, the tight connection with lipids and vesicular processes 
rather suggests that ATP13A2 might be a putative lipid flippase, resembling the closely related P4-
type lipid flippases that regulate lipid signaling and/or membrane curvature. Such a function might 
explain ATP13A2’s pleiotropic effects on exosome release, Zn2+ and Mn2+ homeostasis and toxicity, 
mitochondrial clearance and α-synuclein detoxification 1,2. 
Several reports show that the catalytic activity of ATP13A2 is required to protect cells against various 
insults like mitochondrial stress, α-synuclein toxicity and metal exposure (Zn2+, Mn2+ and Fe3+) 1,6. It 
remains to be established whether all these various cytoprotective effects depend on the same N-
terminal lipid switch. Besides lipid binding, the similarity of the N-terminus with the P1B-type heavy 
metal pumps may hint to a role of the membrane-associated N-terminus in substrate recognition and 
protein interactions (Fig. 1) 2.  
In conclusion, our data highlight the importance of the ATP13A2 N-terminus for lipid interactions, 
autophosphorylation and cell viability. In a variety of model systems ATP13A2 protects against α-
synuclein-, heavy metal- or mitochondrial stress-induced toxicity. Since ATP13A2 may accumulate 
predominantly in an inactive state, targeting the N-terminus may offer a modality to therapeutically 
activate these pro-survival characteristics of ATP13A2.  
 
 
 
 
Legend 
Figure 1. ATP13A2 elicits protective effects against mitochondrial stress. The activity of the 
mitochondrial complex I, residing on the inner membrane of the mitochondria is inhibited by 
rotenone. This elevates the production of reactive oxygen species (ROS), inducing mitochondrial 
stress and mitochondrial damage. Overexpression of the lysosomal P5-type ATPase ATP13A2 elicits a 
protective effect on the cell against this ROS-induced mitochondrial stress. Protection was shown to 
depend on the availability of the signaling lipids PA and PI(3,5)P2, which appear to interact with 
ATP13A2 via its N-terminal membrane-associated region. 
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